Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
10.3762/bjoc.14.284
Saved in:
Main Authors: | Yuan, M, Chua, S.L, Liu, Y, Drautz-Moses, D.I, Hoong Yam, J.K, Aung, T.T, Beuerman, R.W, Santillan Salido, M.M, Schuster, S.C, Tan, C.-H, Givskov, M, Yang, L, Nielsen, T.E |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/178053 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Repurposing the anticancer drug cisplatin with the aim of developing novel
Pseudomonas aeruginosa
infection control agents
by: Yuan, Mingjun, et al.
Published: (2019) -
Identification of novel anti-pathogenic compounds against pseudomonas aeruginosa through drug repurposing
by: Tan, Casandra Ai Zhu
Published: (2017) -
Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
by: Ma, Z, et al.
Published: (2022) -
Selective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms
by: Chua, Song Lin, et al.
Published: (2017) -
Elevated c-di-GMP levels and expression of the type III secretion system promote corneal infection by Pseudomonas aeruginosa
by: Yam, Joey Kuok Hoong, et al.
Published: (2022)